Quick Answer
MAXCYTE, INC. reported Total Assets of $202.51 million for fiscal year 2025.
MAXCYTE, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $202.51M | -15.4% |
| 2024 | $239.47M | -10.7% |
| 2023 | $268.27M | -6.4% |
| 2022 | $286.65M | +0.9% |
| 2021 | $284.12M | +448.7% |
| 2020 | $51.78M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $213.48M | -14.1% | -2.9% |
| June 30, 2025 | $219.75M | -12.6% | -4.4% |
| March 31, 2025 | $229.96M | -10.8% | -4.0% |
| December 31, 2024 | $239.47M | -10.7% | -3.7% |
| September 30, 2024 | $248.61M | -6.8% | -1.1% |
| June 30, 2024 | $251.50M | -7.3% | -2.5% |
| March 31, 2024 | $257.93M | -8.4% | -3.9% |
| December 31, 2023 | $268.27M | -6.4% | +0.6% |
- MAXCYTE, INC. showed a decrease of -15.4% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, MAXCYTE, INC.’s total assets has grown by 291.1% (from $51.78 million to $202.51 million).
- The most recent figure is from MAXCYTE, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: